Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer
3
×
clinical trials
ipo
life sciences
national blog main
national top stories
san francisco blog main
3
×
san francisco top stories
sanofi
3
×
boston top stories
cancer drugs
deals
revolution medicines
san francisco
the column group
third rock ventures
venture capital
warp drive bio
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amgen
amunix
anirvan ghosh
astrazeneca
biogen
bluerock therapeutics
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
cerovene
cobimetinib
colorectal cancer
covid-19
crispr
deerfield management
What
ipo
medicines
3
×
cancer
proteins
research
revolution
acquisitions
announced
bio
cancer’s
ceo
collabs
covid
daniel
deal
despite
disease
drug
family
frontiers
gilead
gilead’s
hardest
help
hit
hottest
hunters
introduce
known
maps
month
o’day
parlance
pharmaceutical
plans
play
ras
reach
reels
revealed
Language
unset
Current search:
medicines
×
cancer
×
sanofi
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers